SE388542B - Forfarande for framstellning av ett vaccin mot virushepatit - Google Patents

Forfarande for framstellning av ett vaccin mot virushepatit

Info

Publication number
SE388542B
SE388542B SE7013590A SE1359070A SE388542B SE 388542 B SE388542 B SE 388542B SE 7013590 A SE7013590 A SE 7013590A SE 1359070 A SE1359070 A SE 1359070A SE 388542 B SE388542 B SE 388542B
Authority
SE
Sweden
Prior art keywords
hepatit
vaccine
virus
procedure
preparation
Prior art date
Application number
SE7013590A
Other languages
English (en)
Inventor
B S Blumberg
I Millman
Original Assignee
Cancer Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Inst filed Critical Cancer Res Inst
Publication of SE388542B publication Critical patent/SE388542B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7013590A 1969-10-08 1970-10-07 Forfarande for framstellning av ett vaccin mot virushepatit SE388542B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86478869A 1969-10-08 1969-10-08

Publications (1)

Publication Number Publication Date
SE388542B true SE388542B (sv) 1976-10-11

Family

ID=25344077

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7013590A SE388542B (sv) 1969-10-08 1970-10-07 Forfarande for framstellning av ett vaccin mot virushepatit

Country Status (7)

Country Link
US (1) US3636191A (sv)
JP (1) JPS5019603B1 (sv)
BE (1) BE786240Q (sv)
DE (1) DE2049515C3 (sv)
FR (1) FR2070112B1 (sv)
GB (1) GB1282984A (sv)
SE (1) SE388542B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
DE2602892A1 (de) * 1976-01-27 1977-07-28 Community Blood Council Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung
JPS5653397Y2 (sv) * 1976-03-11 1981-12-12
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
US4118477A (en) * 1977-02-14 1978-10-03 Merck & Co., Inc. Hepatitis B antigen
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US6268122B1 (en) 1978-12-22 2001-07-31 Biogen, Inc. Recombinant DNA molecules and their method of production
US4242324A (en) * 1979-04-04 1980-12-30 Merck & Co., Inc. Hepatitis B antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4741901A (en) * 1981-12-03 1988-05-03 Genentech, Inc. Preparation of polypeptides in vertebrate cell culture
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
JP2758184B2 (ja) * 1987-06-22 1998-05-28 メデバ ホールディングス ベスローテン ベノートスハップ 肝炎ｂ表面抗原ワクチン
JPS63246335A (ja) * 1987-09-17 1988-10-13 メルク　エンド　カムパニー　インコーポレーテツド 肝炎ｂ抗原
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US11524398B2 (en) 2019-03-19 2022-12-13 Covidien Lp Gear drive mechanisms for surgical instruments

Also Published As

Publication number Publication date
FR2070112B1 (sv) 1974-06-21
JPS5019603B1 (sv) 1975-07-08
DE2049515A1 (de) 1971-04-15
US3636191A (en) 1972-01-18
FR2070112A1 (sv) 1971-09-10
BE786240Q (fr) 1972-11-03
GB1282984A (en) 1972-07-26
DE2049515B2 (de) 1979-12-20
DE2049515C3 (de) 1980-08-21

Similar Documents

Publication Publication Date Title
SE388542B (sv) Forfarande for framstellning av ett vaccin mot virushepatit
NO149176C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
DK132303C (da) Fremgangsmade til fremstilling af en legemiddelform med retarderende virkning
BE787901A (fr) Vaccin antivariolique
SE7604818L (sv) Vaccin
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
FR2282908A1 (fr) Vaccin contre la colibacillose
DK143437C (da) Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
BE794307A (fr) Vaccin anti-caries
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE405805B (sv) Forfarande for framstellning av ett sekretinpreparat med protraherad verkan
DK132447C (da) Fremgangsmade til fremstilling af kalvediarrevirusvaccine
SE398514B (sv) Forfarande for framstellning av ett avdodat blandvaccin for immunisering av fjederfe mot infektioner i andningsvegarna
FI45765C (sv) Förfarande för framställning av tetanusvaccin.
SE396694B (sv) Forfarande for framstellning av en farmaceutisk beredning innehallande ett modifierat allergeniskt material
SE400979B (sv) Forfarande for framstellning av modifierade sampolymerer baserade pa ett cŸ1-cŸ4-alkylakrylat och en omettad flerbasisk karbonsyra anvendbara vid framstellning av lekemedel
FI49522C (sv) Förfarande för framställning av ett stabilt cellfritt viruspreparat
SE425250B (sv) Forfarande for framstellning av vermherdande fenolformaldehydhartser.
SE380795B (sv) Forfarande for framstellning av tiokarbamider
NO141565C (no) Fremgangsmaate for fremstilling av en vaksine mot klovsyke
FI48105C (sv) Förfarande för framställning av ett vaccin
SE384365B (sv) Sett att framstella ett farmaceutiskt anvendbart kalciumsalt av 6-acetyl-amino-hexansyra
SE386075B (sv) Forfarande for framstellning av ett icke-anafylaktiskt pplo-vaccin